Health Care & Life Sciences » Pharmaceuticals | Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. | Income Statement

Fiscal year is January-December. All values ILS Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
73,324
72,506
76,244
84,080
80,518
67,785
Cost of Goods Sold (COGS) incl. D&A
34,677
32,967
32,232
38,557
41,581
37,959
Gross Income
38,647
39,539
44,012
45,524
38,937
29,826
SG&A Expense
24,350
23,470
24,252
27,854
24,582
19,511
EBIT
14,200
16,069
19,760
-
14,356
10,315
Unusual Expense
8,248
1,417
9,181
12,503
79,716
16,535
Non Operating Income/Expense
29
168
233
564
1,827
554
Interest Expense
1,527
1,556
1,807
2,687
2,878
3,807
Pretax Income
4,512
13,014
9,138
3,163
66,109
9,333
Income Tax
155
2,114
2,463
2,000
6,953
701
Equity in Affiliates
144
18
470
31
11
255
Consolidated Net Income
4,523
10,882
6,205
1,194
59,167
8,887
Net Income
4,580
10,928
6,170
1,263
58,505
7,730
Net Income After Extraordinaries
4,580
10,928
6,170
1,263
58,505
7,730
Net Income Available to Common
4,580
10,928
6,111
261
59,440
8,625
EPS (Basic)
5.38
12.81
7.15
0.27
58.49
8.45
Basic Shares Outstanding
849
853
855
955
1,016
1,021
EPS (Diluted)
5.39
12.74
7.07
0.27
58.50
8.45
Diluted Shares Outstanding
850
858
864
961
1,016
1,021
EBITDA
20,127
21,463
24,842
23,328
21,823
16,937
Other Operating Expense
97
-
-
77
-
-
Non-Operating Interest Income
116
86
132
196
302
140
Minority Interest Expense
58
47
35
69
662
1,158
Preferred Dividends
-
-
58
1,002
935
895

About Teva Pharmaceutical Industries

View Profile
Address
5 Basel Street
Petach Tikva HM 49131
Israel
Employees -
Website http://www.tevapharm.com
Updated 07/08/2019
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.